D8Z-25817-58773 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-14
Dose 1 — Pfizer-BioNTech
2021-05-05
Dose 2 — Pfizer-BioNTech
2021-12-18
Dose 3 — Moderna
2021-12-21
Registered in v-safe
2021-12-21
Survey response — days 1–6 daily, dose 3
MedDRA: Haemorrhage in pregnancy — Feeling: Poor · Muscle or body aches · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Potential miscarriage (bleeding)

MedDRA releases: 2024-11 · check-in free text available
2021-12-21
Report sent to call center — days 1–6 daily, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-22
Survey response — days 1–6 daily, dose 3
MedDRA: Vaginal haemorrhage — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Continued vaginal bleeding (potential miscarriage)

MedDRA releases: 2024-11 · check-in free text available
2021-12-22
Report sent to call center — days 1–6 daily, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-22
Call successful
Participant prefers to complete VAERS report online
2021-12-23
Survey response — days 1–6 daily, dose 3
MedDRA: Abortion spontaneous, Vaginal haemorrhage — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Vaginal bleeding (miscarriage)

MedDRA releases: 2024-11 · check-in free text available
2021-12-23
Report sent to call center — days 1–6 daily, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-23
Call 1 — Left Voicemail
2021-12-27
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-14	Pfizer-BioNTech	No
2	2021-05-05	Pfizer-BioNTech	No
3	2021-12-18	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2021-12-21	Successful 2021-12-22	Participant prefers to complete VAERS report online
2021-12-22	Successful	Participant prefers to complete VAERS report online
2021-12-23	Successful 2021-12-27	Participant prefers to complete VAERS report online

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-21

Systemic reaction (other): Potential miscarriage (bleeding)

2021-12-22

Systemic reaction (other): Continued vaginal bleeding (potential miscarriage)

2021-12-23

Systemic reaction (other): Vaginal bleeding (miscarriage)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Abortion spontaneous	·	·	✓
SRO	Haemorrhage in pregnancy	·	·	✓
SRO	Vaginal haemorrhage	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release